Last reviewed · How we verify

NCT04133961

Intraoperative Phenylephrine Infusion to Reduce Postoperative Shivering in Lower Segment Caesarean Section

Completed NA Last updated 8 July 2020
What this trial tests

NA trial testing Phenylephrine in Postoperative Shivering in 118 participants. Completed in 1 January 2020.

Timeline
12 June 2019
Primary endpoint
1 December 2019
1 January 2020

Quick facts

Lead sponsorUniversiti Kebangsaan Malaysia Medical Centre
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeprevention
Enrollment118
Start date12 June 2019
Primary completion1 December 2019
Estimated completion1 January 2020
Sites1 location across Malaysia

Drugs / interventions tested

Conditions studied

Sponsor

Universiti Kebangsaan Malaysia Medical Centre — full company profile →

Who can join

18 and older, female only, with Postoperative Shivering. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Assessment of whether and how phenylephrine infusion reduces postoperative shivering in spinal anaesthesia.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Intraoperative phenylephrine infusion to reduce perioperative shivering in lower segment caesarean section: A randomised controlled study.
    Tan Sook Kuan J, Musthafa QA, Abdullah FH, Sayed Masri SNN. · · 2023 · cited 3× · PMID 37171298 · DOI 10.1097/md.0000000000033721

Verify or expand the search:

Other trials of Phenylephrine

Trials testing the same drug.

Other recruiting trials for Postoperative Shivering

Currently open trials in the same condition.

Other Universiti Kebangsaan Malaysia Medical Centre trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04133961.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing